SunTrust analyst Youssef Squali noted that Cardlytics has disclosed a series of triggered insider sales in recent days, but points out that a footnote to the filings makes clear that one of the criteria needed to trigger the accelerated vesting was that MAUs exceeded 85M for a given month. The analyst, who suspects that the period in question is November, noted that 85M MAUs hinted at in the filing tops his Q4 estimate of 63M and the consensus estimate of 64.4M. MAU growth creates more ad inventory and is a precursor to revenue growth, said Squali, who has a Buy rating and $27 price target on Cardlytics shares.